Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Respiratory Infections”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04617119
What this trial is testing

The Effects of Multi-modality Physiotherapy in Delaying or Preventing COVID-19 Patient From Admitting to ICU

Who this might be right for
Covid19Severe Systemic Illness Respiratory Muscle Fatigue
DR. JASSIM ALGHAITH 38
Testing effectiveness (Phase 2)Ended earlyNCT04370834
What this trial is testing

Tocilizumab for Patients With Cancer and COVID-19 Disease

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmPneumonia+3 more
National Cancer Institute (NCI) 1
Not applicableStudy completedNCT04390165
What this trial is testing

Malaysian COVID-19 Anosmia Study (Phase 1) - A Nationwide Multicentre Cross-Sectional Study

Who this might be right for
SARS-CoV InfectionCOVID-19Anosmia+1 more
Hospital Sultanah Bahiyah 498
Post-approval studies (Phase 4)UnknownNCT04350671
What this trial is testing

Interferon Beta 1a in Hospitalized COVID-19 Patients

Who this might be right for
COVID-19
Shahid Beheshti University of Medical Sciences 40
Post-approval studies (Phase 4)Study completedNCT00406198
What this trial is testing

Impact of Continuous Venovenous Haemofiltration on Organ Failure During the Early Phase of Severe Sepsis

Who this might be right for
BacteremiaGram-Negative Bacterial InfectionsGram-Positive Bacterial Infections+3 more
Hopital Lariboisière 400
Not applicableStudy completedNCT04371471
What this trial is testing

Pandemic Triage Score in Patients With Known or Suspected Severe Acute Respiratory Syndrome (SARS) CoronaVirus (CoV) 2 Infection

Who this might be right for
SARS-CoV-2 Acute Respiratory DiseaseCovid19
Groupe Hospitalier de la Rochelle Ré Aunis 91
Not applicableWithdrawnNCT00172263
What this trial is testing

The Interaction Between Severe Acute Respiratory Distress Syndrome Viral Proteins and Monocytes

Who this might be right for
Severe Acute Respiratory Syndrome
National Taiwan University Hospital
Large-scale testing (Phase 3)Ended earlyNCT04341727
What this trial is testing

Hydroxychloroquine,Hydroxychloroquine,Azithromycin in the Treatment of SARS CoV-2 Infection

Who this might be right for
Coronavirus Infection
Washington University School of Medicine 30
Not applicableUnknownNCT04178382
What this trial is testing

Effect of PCR-CRISPR/Cas12a on the Early Anti-infective Schemes in Patients With Open Air Pneumonia

Who this might be right for
Severe Sepsis
Chinese Medical Association 146
Not applicableActive Not RecruitingNCT07634328
What this trial is testing

Impact of a High-Protein Diet on Clinical Outcomes in Mechanically Ventilated Patients With Severe Pneumonia

Who this might be right for
Mechanically Ventilated PatientsSevere Pneumonia
Fayoum University 60
Large-scale testing (Phase 3)Study completedNCT02714595
What this trial is testing

Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens

Who this might be right for
Healthcare-associated Pneumonia (HCAP)Bloodstream Infections (BSI)Hospital Acquired Pneumonia (HAP)+3 more
Shionogi 152
Not applicableNo Longer AvailableNCT04337359
What this trial is testing

Ruxolitinib Managed Access Program (MAP) for Patients Diagnosed With Severe/Very Severe COVID-19 Illness

Who this might be right for
Severe/Very Severe COVID-19 Illness
Novartis Pharmaceuticals
Early research (Phase 1)Study completedNCT05220605
What this trial is testing

Nebulised BromAc in Healthy Volunteers

Who this might be right for
COVID-19 PneumoniaBromelains Adverse ReactionAcetylcysteine Adverse Reaction+2 more
Mucpharm Pty Ltd 12
Large-scale testing (Phase 3)WithdrawnNCT04372082
What this trial is testing

Hydroxychloroquine or Diltiazem-Niclosamide for the Treatment of COVID-19

Who this might be right for
Sars-CoV2
University Hospital, Lille
Testing effectiveness (Phase 2)Study completedNCT04745442
What this trial is testing

Pilot Study of Antithrombin as Prophylaxis of Acute Respiratory Distress Syndrome in Patients With COVID-19

Who this might be right for
Covid19Severe Acute Respiratory SyndromeDistress Respiratory Syndrome
Maimónides Biomedical Research Institute of Córdoba 48
Not applicableStudy completedNCT04889313
What this trial is testing

Post COVID-19 Neurologic Symptoms : a Somatic Spectrum Disorder ? (SOMATiC)

Who this might be right for
COVID-19
Centre Hospitalier de Saint-Denis 50
Not applicableStudy completedNCT05303103
What this trial is testing

Using Mixed-methods Approach to Explore the Long-term Effects of COVID-19

Who this might be right for
Covid19
National Taiwan University Hospital 150
Post-approval studies (Phase 4)Study completedNCT04326920
What this trial is testing

Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC)

Who this might be right for
COVID-19
University Hospital, Ghent 87
Not applicableStudy completedNCT06402279
What this trial is testing

Hemoperfusion Efferon СT for the Extremely Severe Form of COVID-19

Who this might be right for
COVID-19
Efferon JSC 130
Not applicableStudy completedNCT03497962
What this trial is testing

P4 Peptide in Community Acquired Pneumonia

Who this might be right for
Pneumonia
Liverpool University Hospitals NHS Foundation Trust 32
Next Page